Monitoring carboplatin ototoxicity with distortion-product otoacoustic emissions in children with retinoblastoma

OBJECTIVE: Carboplatin is a common chemotherapy agent with potential ototoxic side effects that is used to treat a variety of pediatric cancers, including retinoblastoma. Retinoblastoma is a malignant tumor of the retina that is usually diagnosed in young children. Distortion-product otoacoustic emi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Pediatr Otorhinolaryngol
Egile Nagusiak: Bhagat, Shaum P., Bass, Johnnie K., White, Stephanie T., Qaddoumi, Ibrahim, Wilson, Matthew W., Wu, Jianrong, Rodriguez-Galindo, Carlos
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4787621/
https://ncbi.nlm.nih.gov/pubmed/20667604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijporl.2010.07.004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak